Scopolamine placebo

DRUG2 trials

Sponsors

Takeda, Tetra Discovery Partners

Conditions

Alzheimer DiseaseHealthy Volunteers

Phase 1

TAK-071 Scopolamine-Induced Cognitive Impairment Study

TerminatedNCT02918266

TakedaHealthy Volunteers

Start: 2016-11-21End: 2017-08-08Updated: 2019-06-14

Study to Evaluate the Effects of BPN14770 on Scopolamine-induced Cognitive Impairment in Healthy Volunteers

CompletedNCT03030105

Tetra Discovery PartnersAlzheimer Disease

Start: 2017-01-31End: 2017-06-30Updated: 2018-10-16